サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1418431

皮膚糸状菌性爪真菌症治療市場レポート：2030年までの動向、予測、競合分析

Dermatophytic Onychomycosis Treatment Market Report: Trends, Forecast and Competitive Analysis to 2030

出版日
発行
Lucintel
ページ情報
英文 150 - page report
納期
3営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円

ご注意:　DRM (デジタル著作権管理システム) 付PDFになります。
制限内容は、上記ライセンスの[詳細]アイコンをクリックしてご確認ください。

皮膚糸状菌性爪真菌症治療市場レポート：2030年までの動向、予測、競合分析
出版日: 2024年01月29日
発行: Lucintel
ページ情報: 英文 150 - page report
納期: 3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

皮膚糸状菌性爪真菌症治療の動向と予測

世界の皮膚糸状菌性爪真菌症治療市場は、2024年から2030年までのCAGRが4.5%で、2030年までに推定45億米ドルに達すると予想されます。この市場の主な促進要因は、糖尿病患者の増加、高齢者の増加、研究の増加、マニキュアの急速な普及、新しいジェネリック医薬品の導入急増による爪真菌症の発生率の増加です。世界の皮膚糸状菌性爪真菌症治療薬市場の将来は、処方薬市場と市販薬市場に機会があり、有望視されています。

皮膚糸状菌性爪真菌症治療市場洞察

Lucintelの予測では、ジュブリアの採用が増加しているため、予測期間中はネイルペイントがより大きなセグメントであり続けると思われます。

この市場の中では、シクロピロックスの売上が急増しているため、市販薬が引き続き大きなセグメントとなると思われます。

北米は爪白癬治療の処方件数が増加しているため、予測期間中も最大の地域です。

よくある質問

Q1.市場規模は？

A1.世界の皮膚糸状菌性爪白癬治療市場は、2030年までに推定45億米ドルに達すると予想されています。

Q2.市場の成長予測は？

A2.世界の皮膚糸状菌性爪白癬治療市場は、2024年から2030年にかけてCAGR 4.5%で成長すると予測されます。

Q3.市場の成長に影響を与える主な促進要因は？

A3.この市場の主な促進要因は、糖尿病の頻度増加、高齢者の増加、研究の増加、マニキュアの急速な普及、新しいジェネリック医薬品のイントロダクションの急増によって引き起こされる爪真菌感染症の発生率の増加です。

Q4.市場の主要セグメントは？

A4.皮膚糸状菌性爪真菌症治療薬市場の将来は、処方薬市場と市販薬市場にチャンスがあり、有望です。

Q5.市場の主要企業は？

A5.皮膚糸状菌性爪白癬治療薬の主要企業は以下の通りです。

  • Bausch Health Companies
  • Pfizer
  • Galderma
  • GlaxoSmithKline
  • Janssen Pharmaceuticals
  • Cipla
  • Kaken Pharmaceuticals

Q6.今後、最大となる市場セグメントは？

A6.Lucintelは、ジュブリアの採用が増加しているため、予測期間中はネイルペイントがより大きなセグメントであり続けると予測しています。

Q7.市場において、今後5年間に最大になると予想される地域は？

A7.北米は、爪白癬治療の処方件数の増加により、予測期間中も最大の地域であり続ける。

Q8.レポートのカスタマイズは可能？

A8.はい、Lucintelは追加費用なしで10％のカスタマイズを提供します。

目次

第1章 エグゼクティブサマリー

第2章 世界の皮膚糸状菌性爪真菌症治療市場：市場力学

  • イントロダクション、背景、分類
  • サプライチェーン
  • 業界の促進要因と課題

第3章 2018年～2030年の市場動向と予測分析

  • マクロ経済動向（2018年～2023年）と予測（2024年～2030年）
  • 世界の皮膚糸状菌症爪真菌症治療市場の動向（2018年～2023年）と予測（2024年～2030年）
  • 世界の皮膚糸状菌性爪真菌症治療市場、製品タイプ別
    • タブレット
    • ネイルペイント
  • 世界の皮膚糸状菌性爪真菌症治療市場、投与経路別
    • 経口
    • 局所
  • 世界の皮膚糸状菌性爪真菌症治療市場、タイプ別
    • 所定
    • 店頭
  • 世界の皮膚糸状菌性爪真菌症治療市場、販売チャネル別
    • 病院薬局
    • 小売薬局
    • オンラインチャネル

第4章 2018年～2030年の地域別の市場動向と予測分析

  • 地域別の世界の皮膚糸状菌症爪真菌症治療市場
  • 北米の皮膚糸状菌性爪真菌症治療市場
  • 欧州の皮膚糸状菌性爪真菌症治療市場
  • アジア太平洋の皮膚糸状菌症爪真菌症治療市場
  • その他地域の皮膚糸状菌性爪真菌症治療市場

第5章 競合の分析

  • 製品ポートフォリオ分析
  • 運用上の統合
  • ポーターのファイブフォース分析

第6章 成長機会と戦略的分析

  • 成長機会分析
    • 製品タイプ別の世界の皮膚糸状菌性爪真菌症治療市場の成長機会
    • 投与経路別の世界の皮膚糸状菌性爪真菌症治療市場の成長機会
    • タイプ別の世界の皮膚糸状菌性爪真菌症治療市場の成長機会
    • 流通チャネル別の世界の皮膚糸状菌性爪真菌症治療市場の成長機会
    • 地域別の世界の皮膚糸状菌性爪真菌症治療市場の成長機会
  • 世界の皮膚糸状菌性爪真菌症治療市場の新たな動向
  • 戦略的分析
    • 新製品の開発
    • 世界の皮膚糸状菌性爪真菌症治療市場の能力拡大
    • 世界の皮膚糸状菌性爪真菌症治療市場における合併、買収、合弁事業
    • 認証とライセンシング

第7章 有力企業の企業プロファイル

  • Bausch Health Companies
  • Pfizer
  • Galderma
  • GlaxoSmithKline
  • Janssen Pharmaceuticals
  • Cipla
  • Kaken Pharmaceuticals
目次

Dermatophytic Onychomycosis Treatment Trends and Forecast

The future of the global dermatophytic onychomycosis treatment market looks promising with opportunities in the prescribed and over-the-counter markets. The global dermatophytic onychomycosis treatment market is expected to reach an estimated $4.5 billion by 2030 with a CAGR of 4.5% from 2024 to 2030. The major drivers for this market are increased incidence of nail fungal infections is caused by the rising frequency of diabetes, growing number of elderly people, and growing research, the quick uptake of nail polish, and the surge in the introduction of new generic medication.

A more than 150-page report is developed to help in your business decisions.

Dermatophytic Onychomycosis Treatment by Segment

The study includes a forecast for the global dermatophytic onychomycosis treatment by product type, route of administration, type, distribution channel, and region.

Dermatophytic Onychomycosis Treatment Market by Product Type [Shipment Analysis by Value from 2018 to 2030]:

  • Tablets
  • Nail Paints

Dermatophytic Onychomycosis Treatment Market by Route of Administration [Shipment Analysis by Value from 2018 to 2030]:

  • Oral
  • Topical

Dermatophytic Onychomycosis Treatment Market by Type [Shipment Analysis by Value from 2018 to 2030]:

  • Prescribed
  • Over-The-Counter

Dermatophytic Onychomycosis Treatment Market by Distribution Channel [Shipment Analysis by Value from 2018 to 2030]:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Channels

Dermatophytic Onychomycosis Treatment Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Dermatophytic Onychomycosis Treatment Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies dermatophytic onychomycosis treatment companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the dermatophytic onychomycosis treatment companies profiled in this report include-

  • Bausch Health Companies
  • Pfizer
  • Galderma
  • GlaxoSmithKline
  • Janssen Pharmaceuticals
  • Cipla
  • Kaken Pharmaceuticals

Dermatophytic Onychomycosis Treatment Market Insights

Lucintel forecasts that nail paints will remain the larger segment over the forecast period due to increasing adoption of jublia.

Within this market, over-the-counter will remain the larger segment due to rapidly increasing ciclopirox sales.

North America will remain the largest region over the forecast period due to rising count of prescriptions for onychomycosis treatment.

Features of the Global Dermatophytic Onychomycosis Treatment Market

Market Size Estimates: Dermatophytic onychomycosis treatment market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Dermatophytic onychomycosis treatment market size by various segments, such as by product type, route of administration, type, distribution channel, and region in terms of value ($B).

Regional Analysis: Dermatophytic onychomycosis treatment market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different product type, route of administration, type, distribution channel, and regions for the dermatophytic onychomycosis treatment market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the dermatophytic onychomycosis treatment market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the dermatophytic onychomycosis treatment market size?

Answer: The global dermatophytic onychomycosis treatment market is expected to reach an estimated $4.5 billion by 2030.

Q2. What is the growth forecast for dermatophytic onychomycosis treatment market?

Answer: The global dermatophytic onychomycosis treatment market is expected to grow with a CAGR of 4.5% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the dermatophytic onychomycosis treatment market?

Answer: The major drivers for this market are increased incidence of nail fungal infections is caused by the rising frequency of diabetes, growing number of elderly people, and growing research, the quick uptake of nail polish, and the surge in the introduction of new generic medication.

Q4. What are the major segments for dermatophytic onychomycosis treatment market?

Answer: The future of the dermatophytic onychomycosis treatment market looks promising with opportunities in the prescribed and over-the-counter markets.

Q5. Who are the key dermatophytic onychomycosis treatment market companies?

Answer: Some of the key dermatophytic onychomycosis treatment companies are as follows.

  • Bausch Health Companies
  • Pfizer
  • Galderma
  • GlaxoSmithKline
  • Janssen Pharmaceuticals
  • Cipla
  • Kaken Pharmaceuticals

Q6. Which dermatophytic onychomycosis treatment market segment will be the largest in future?

Answer: Lucintel forecasts that nail paints will remain the larger segment over the forecast period due to increasing adoption of jublia.

Q7. In dermatophytic onychomycosis treatment market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period due to rising count of prescriptions for onychomycosis treatment.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the dermatophytic onychomycosis treatment market by product type (tablets and nail paints), route of administration (oral and topical), type (prescribed and over-the-counter), distribution channel (hospital pharmacies, retail pharmacies, and online channels), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Dermatophytic Onychomycosis Treatment Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Dermatophytic Onychomycosis Treatment Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Dermatophytic Onychomycosis Treatment Market by Product Type
    • 3.3.1: Tablets
    • 3.3.2: Nail Paints
  • 3.4: Global Dermatophytic Onychomycosis Treatment Market by Route of Administration
    • 3.4.1: Oral
    • 3.4.2: Topical
  • 3.5: Global Dermatophytic Onychomycosis Treatment Market by Type
    • 3.5.1: Prescribed
    • 3.5.2: Over-the-Counter
  • 3.6: Global Dermatophytic Onychomycosis Treatment Market by Distribution Channel
    • 3.6.1: Hospital Pharmacies
    • 3.6.2: Retail Pharmacies
    • 3.6.3: Online Channels

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Dermatophytic Onychomycosis Treatment Market by Region
  • 4.2: North American Dermatophytic Onychomycosis Treatment Market
    • 4.2.2: North American Dermatophytic Onychomycosis Treatment Market by Type: Prescribed and Over-the-Counter
  • 4.3: European Dermatophytic Onychomycosis Treatment Market
    • 4.3.1: European Dermatophytic Onychomycosis Treatment Market by Product Type: Tablets and Nail Paints
    • 4.3.2: European Dermatophytic Onychomycosis Treatment Market by Type: Prescribed and Over-the-Counter
  • 4.4: APAC Dermatophytic Onychomycosis Treatment Market
    • 4.4.1: APAC Dermatophytic Onychomycosis Treatment Market by Product Type: Tablets and Nail Paints
    • 4.4.2: APAC Dermatophytic Onychomycosis Treatment Market by Type: Prescribed and Over-the-Counter
  • 4.5: ROW Dermatophytic Onychomycosis Treatment Market
    • 4.5.1: ROW Dermatophytic Onychomycosis Treatment Market by Product Type: Tablets and Nail Paints
    • 4.5.2: ROW Dermatophytic Onychomycosis Treatment Market by Type: Prescribed and Over-the-Counter

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Dermatophytic Onychomycosis Treatment Market by Product Type
    • 6.1.2: Growth Opportunities for the Global Dermatophytic Onychomycosis Treatment Market by Route of Administration
    • 6.1.3: Growth Opportunities for the Global Dermatophytic Onychomycosis Treatment Market by Type
    • 6.1.4: Growth Opportunities for the Global Dermatophytic Onychomycosis Treatment Market by Distribution Channel
    • 6.1.5: Growth Opportunities for the Global Dermatophytic Onychomycosis Treatment Market by Region
  • 6.2: Emerging Trends in the Global Dermatophytic Onychomycosis Treatment Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Dermatophytic Onychomycosis Treatment Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Dermatophytic Onychomycosis Treatment Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Bausch Health Companies
  • 7.2: Pfizer
  • 7.3: Galderma
  • 7.4: GlaxoSmithKline
  • 7.5: Janssen Pharmaceuticals
  • 7.6: Cipla
  • 7.7: Kaken Pharmaceuticals